Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 36.7893.14298.54-62.910.46

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 36.78 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202536.78
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 36.78
-60.51
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,737.8 Cr 0.7% 13.8% -32.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,248.0 Cr -0.4% 6.4% 4.2% Stock Analytics
DIVIS LABORATORIES ₹171,344.0 Cr -1.5% -4.9% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,832.0 Cr -0.7% 4.8% 16.6% Stock Analytics
CIPLA ₹121,820.0 Cr -0.5% 1% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,877.0 Cr 2.2% 6.6% 5.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.7%

13.8%

-32.5%

SENSEX

-0.6%

1.4%

7.7%


You may also like the below Video Courses